收藏切换
Clinical trial of remazolam combined with alfentanil in the treatment of patients with hysteroscopic surgery
收藏切换
PDF
Ke-lu XU, Qin SHEN, Tong WU, Yue CHENG
Chinese Journal of Clinical Pharmacology | 2025, 41(5) : 626 - 630
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(5): 626-630
Clinical and Basic Bridging Research
Clinical trial of remazolam combined with alfentanil in the treatment of patients with hysteroscopic surgery
Full
Ke-lu XU, Qin SHEN, Tong WU, Yue CHENG
Affiliations
  • Department of Anesthesiology, Huainan Xinhua Hospital Affiliated to Anhui University of Science & Technology, Huainan 232052, Anhui Province, China
Published: 2025-03-17 doi: 10.13699/j.cnki.1001-6821.2025.05.006
Outline
收藏切换
Objective

To observe the anesthetic effects and safety of remazolam injection combined with alfentanil injection in the treatment of patients with hysteroscopic surgery.

Methods

Patients scheduled for hysteroscopic surgery were randomly divided into control group and treatment group. The control group received intravenous 1.5-2.0 mg·kg-1 propofol + 7-10 μg·kg-1 alfentanil for anesthetic induction, during the surgery, continuously infused with 4-12 mg·kg-1·h-1 propofol + 0.05-0.20 μg·kg-1·h-1 remifentanil for anesthesia maintenance. The treatment group was given intravenous 0.3-0.5 mg·kg-1 remimazolam + 7-10 μg·kg-1 alfentanil for anesthetic induction, during the surgery, received 0.5-1.0 mg·kg-1·h-1remazolam+ 0.05-0.20 μg·kg-1·h-1 remifentanil for anesthesia maintenance. The hemodynamics, analgesic effects, cognitive function and safety were compared between the two groups.

Results

Control group were enrolled 52 cases, 3 cases dropped out, and 49 cases were finally included in the statistical analysis. Treatment group were enrolled 53 cases, 4 cases dropped out, and 49 cases were finally included in the statistical analysis. At the end of the surgery, the mean arterial pressure of treatment and control groups were (73.98±7.41) and (60.10±6.84) mmHg, the heart rates were (68.43±7.32) and (63.92±7.36) beat·min-1, the differences of above index were statistically significant between two groups (all P<0.05). One hour after operation, the visual analogue scale scores of treatment and control groups were (3.08±0.49) and (3.86±0.61) points, the mini-mental state examination scores were (22.65±2.41) and (18.24±2.38) points, the differences were statistically significant (all P<0.05). The adverse drug reactions of treatment group were nausea, while those in the control group were bradycardia, hypotension, respiratory depression and nausea. The total incidences of adverse drug reactions in the treatment and control groups were 2.04% and 14.29%, with statistically significant difference (P<0.05).

Conclusion

Remazolam injection combined with alfentanil injection can help to maintain hemodynamics of patients with hysteroscopic surgery, reduce the risk of postoperative pain and cognitive impairment, with good safety.

remazolam injection  /  alfentanil injection  /  propofol injection  /  hysteroscopic surgery  /  safety evaluation
Ke-lu XU, Qin SHEN, Tong WU, Yue CHENG. Clinical trial of remazolam combined with alfentanil in the treatment of patients with hysteroscopic surgery[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (5) : 626 -630 . DOI: 10.13699/j.cnki.1001-6821.2025.05.006
Year 2025 volume 41 Issue 5
PDF
0
0
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.05.006
  • Receive Date:2024-09-23
  • Online Date:2026-08-04
  • Published:2025-03-17
Article Data
Affiliations
History
  • Received:2024-09-23
Funding
Affiliations
    Department of Anesthesiology, Huainan Xinhua Hospital Affiliated to Anhui University of Science & Technology, Huainan 232052, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.05.006
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT